ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

OCX Oncocyte Corporation

2.77
0.11 (4.14%)
取引時間後
最終更新日: 06:43:49
15分遅延
名称 銘柄コード 市場 種別
Oncocyte Corporation OCX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.11 4.14% 2.77 06:43:49
始値 安値 高値 終値 前日終値
2.69 2.59 2.84 2.77 2.66
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1219:00GLOBEOncocyte Reports Full Year 2023 Financial Results
2024/4/1210:46GLOBEOncocyte Corporation Announces $15.8 Million Private..
2024/4/1206:30GLOBEOncocyte and Bio-Rad Partner on Global Launch of Transplant..
2024/4/1005:05GLOBEOncocyte to Announce Fourth Quarter and Full Year 2024..
2024/1/2406:39EDGAR2Form 8-K - Current report
2024/1/1622:00GLOBEOncocyte to Present at the Sequire Investor Summit in Puerto..
2023/12/0622:00GLOBEOncocyte Begins FDA Submissions Process for VitaGraft..
2023/11/1007:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0921:05EDGAR2Form 8-K - Current report
2023/11/0921:00GLOBEOncocyte Reports Third Quarter 2023 Financial Results
2023/11/0321:30GLOBEOncocyte to Announce Third Quarter 2023 Financial Results
2023/10/1305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1105:48EDGAR2Form 8-K/A - Current report: [Amend]
2023/10/0605:05EDGAR2Form 8-K - Current report
2023/9/2022:00EDGAR2Form 8-K - Current report
2023/8/2905:05EDGAR2Form 8-K - Current report
2023/8/1807:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1105:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1020:05EDGAR2Form 8-K - Current report
2023/7/2522:08GLOBEVitaGraft Kidney Expands Utility in Recurrent Primary..
2023/7/2506:28EDGAR2Form 8-K - Current report
2023/7/2502:35GLOBEOncocyte Announces 1-For-20 Reverse Stock Split
2023/7/2206:16EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/7/1419:03EDGAR2Form 8-K - Current report
2023/7/1100:20EDGAR2Form DEF 14A - Other definitive proxy statements
2023/7/0407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/0105:14EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/6/3005:05EDGAR2Form 8-K - Current report
2023/6/2721:30GLOBEOncocyte Begins Manufacturing Transplant Blood Test
2023/5/1121:00GLOBEOncocyte Reports First Quarter 2023 Financial Results

最近閲覧した銘柄

Delayed Upgrade Clock